These include inconsistencies in study designs (e.g., cross-sectional vs. longitudinal), variations in sample characteristics (age, sex, severity of depression, comorbid conditions), and differences in the methods used to measure uPA, tPA, PAI-1, and BDNF. The gene discussed is PLAU; the disease is depressive symptom measurement.